Cytovia cytovia.com


Public lists: Pharma Startups (4732)

Commercializes a patented drug screening technology through partnerships with large pharmaceutical companies and clinical testing service companies. Cytovia (NASDAQ: MAXM) was acquired by Maxim Pharmaceuticals, Inc. in June 2000.

Commercializes a patented drug screening technology through partnerships with large pharmaceutical companies and clinical testing service companies. Cytovia (NASDAQ: MAXM) was acquired by Maxim Pharmaceuticals, Inc. in June 2000.

Company (Acquired)

Phone: 858-860-0500

Fax:

6650 Nancy Ridge Drive

Irvine, 92121
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cytovia $15.4M Jun 21, 2000
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cytovia Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Rapid Laboratory Microsystems

Ontario, Canada
Alive / ActiveRapidLabs will revolutionize antibiotic susceptibility testing (AST) and bacterial identification (ID) activities in clinical microbiology. The company's technology measures microbial respiration rather than growth, which aims to improve the time to result, and aims to provide for greater efficiency in the microbiology lab.Login to see details

Active Pass Pharmaceuticals

British Columbia, Canada
Alive / ActiveActive Pass is a Canadian biotechnology company that is engaging in genomic-based drug discovery and is developing drugs that inhibit ABC transporters. ABC or (ATP binding cassette) is a term that describes the interconnected group of molecular engines or pumps that function as a transportation system which moves compounds across the biological membranes. These ABCs are very closely associated with human diseases like Alzheimer's disease, diabetes, asthma, and hypertension. The Active Pass mana...Show allLogin to see details
See all 14 competitors